Funder
The Association of the British Pharmaceutical Industry
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics and Econometrics,General Medicine
Reference98 articles.
1. Santos AS, Guerra-Junior AA, Godman B, Morton A, Ruas CM. Cost-effectiveness thresholds: methods for setting and examples from around the world. Expert Rev Pharmacoecon Outcomes Res. 2018;18:277–88.
2. Zhang K, Garau M. International cost-effectiveness thresholds and modifiers for HTA decision making. OHE Consulting Report. 2020. https://www.ohe.org/publications/international-cost-effectiveness-thresholds-and-modifiers-hta-decision-making. Accessed 25 Apr 2022.
3. Thokala P, Ochalek J, Leech AA, Tong T. Cost-effectiveness thresholds: the past, the present and the future. Pharmacoeconomics. 2018;36:509–22.
4. Lomas J, Ochalek J, Faria R. Avoiding opportunity cost neglect in cost-effectiveness analysis for health technology assessment. Appl Health Econ Health Policy [Internet]. 2021. https://doi.org/10.1007/s40258-021-00679-9 (cited 2021 Sep 16).
5. Ryen L, Svensson M. The willingness to pay for a quality adjusted life year: a review of the empirical literature. Health Econ. 2015;24:1289–301.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献